Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen fumarate plus celecoxib after release surgery for post-traumatic elbow stiffness
ChiCTR2300078332Phase 2Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jun 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of celecoxib and ketotifen in Elbow contracture, sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Change in elbow flexion-extension range of motion at the end of treatment compared with intraoperative range after release. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
celecoxibketotifen
03
Conditions
Elbow contracture
Beyond the preview
Go deeper on ChiCTR2300078332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078332.